Pharmacodynamic and Pharmacokinetic Dose Ranging Study of Tiotropium Bromide Administered Via Inhalation Solution in Patients With Chronic Obstructive Pulmonary Disease (COPD)
Clinical trial NCT03118765 · COMPLETED
Trial details
- NCT number
- NCT03118765
- Sponsor
- Glenmark Specialty S.A.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-03-24
- Primary completion
- 2017-07-31
- Enrollment
- 155
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.